OIE Innovation Webinar Series

Please register on this page.

OIE Innovation Webinar Series

The OIE Innovation Webinar Series is an opportunity for innovators of all stages within the Pitt community to learn about the various resources within and outside of Pitt's Office of Innovation and Entrepreneurship to support you at each step along your journey to commercialization and/or startup creation.

 

The series is presented by the University of Pittsburgh's Office of Innovation and Entrepreneurship.


Upcoming Sessions:

Sept 18:  “Communicating with Impact: The Art of Entrepreneurial Storytelling”

 

Time: 1-2 p.m. EST

Presenter: Otto Pohl

Startup Communications Strategist

Core Communications

When turning your research into a startup, it is crucial to communicate your idea in a way that both captures and holds your audience's attention while conveying key information you want to get across. This is a fast-paced webinar that will help you tell your story better so that you can succeed faster. The presentation will be followed by Q&A—bring your questions and leave with answers!

Highlights of this webinar include:

  • The two critical mindset shifts you need to successfully transition from academia to business
  • The framework you should use to tell your story to any audience
  • How Pohl’s Messaging Pyramid helps you position your product or service better
  • How to build your website’s Narrative Triangle

 

Otto Pohl_headshotOtto Pohl helps deep tech entrepreneurs tell their company story better. His background as a journalist, serial entrepreneur, and Head of Communications for startups has made him a leading industry expert and gives him unique experience to help university-based innovators tell more effective stories to customers, partners, and investors to make a successful transition from academia to business. Otto has a BA in government from Cornell, a business master’s from Stanford, and has taught Entrepreneurial Communications at USC.

 

 

 

 

Future sessions to be announced! 

Previous Sessions:

 

Jul 10:  “National Institute of Health (NIH)’s SBIR/STTR Programs: Funding and Commercialization Support for Scientist Entrepreneurs and Early-Stage Startups”

 

Time: 1-2 p.m. EST

 

Presenter: Swamy Tripurani, PhD

Program Director, SBIR Development Center

National Cancer Institute

 

The federal Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs are a critical source of non-dilutive funding for early-stage companies. The National Cancer Institute (NCI), the largest National Institutes of Health (NIH) organization, offers SBIR and STTR programs that provide approximately $200 million annually to US small businesses for developing and commercializing novel cancer technologies. In addition to funding, the NCI SBIR Development Center offers various commercialization resources to support small businesses in getting their products into the market.

 

Join this webinar to learn about:

❖ An overview of federal SBIR/STTR programs at the National Institutes of Health (NIH) with specifics relating to the National Cancer Institute (NCI), the largest NIH Institute.
 
❖ Funding opportunities for startups, academic spinout companies, and early-stage academic entrepreneurs (e.g., postdoctoral fellows), such as the NCI SBIR Innovative Concept Award and the Small Business Transition Grant for New Entrepreneurs
 
❖ Tips for writing competitive SBIR/STTR grant proposals.
 
❖ Commercialization resources for applicants and awardees
 

Swamy Tripurani_PicDr. Swamy Tripurani is a Program Director at the Small Business Innovation Research (SBIR) Development Center at the National Cancer Institute (NCI). Dr. Tripurani oversees a portfolio of grants and contracts to support the development of innovative cancer therapeutics, digital health technologies, and therapeutic devices by small businesses. He also co-manages the CARE (Connecting Awardees with Regulatory Experts) program, which fosters interactions between NCI-funded small businesses and the Food and Drug Administration (FDA). Before joining NCI, Dr. Tripurani worked as a regulatory scientist at the FDA for eight years. Dr. Tripurani earned his Ph.D. in Genetics and Developmental Biology from West Virginia University and completed his postdoctoral research training focused on gynecologic cancers and reproductive disorders at Baylor College of Medicine.  

 

 

.

Register here: